Published in Br J Pharmacol on June 01, 2003
Radiolabeled somatostatin receptor antagonists are preferable to agonists for in vivo peptide receptor targeting of tumors. Proc Natl Acad Sci U S A (2006) 1.52
Functional characterization of human variants of the mu-opioid receptor gene. Proc Natl Acad Sci U S A (2009) 1.07
Topical application of entry inhibitors as "virustats" to prevent sexual transmission of HIV infection. Retrovirology (2008) 0.97
Neuropeptide Y overexpression using recombinant adeno-associated viral vectors. Neurotherapeutics (2009) 0.93
Illuminating the life of GPCRs. Cell Commun Signal (2009) 0.92
Internalization of the human nicotinic acid receptor GPR109A is regulated by G(i), GRK2, and arrestin3. J Biol Chem (2010) 0.90
Quantitative analysis of neuropeptide Y receptor association with beta-arrestin2 measured by bimolecular fluorescence complementation. Br J Pharmacol (2010) 0.90
BODIPY-conjugated neuropeptide Y ligands: new fluorescent tools to tag Y1, Y2, Y4 and Y5 receptor subtypes. Br J Pharmacol (2005) 0.83
Neuropeptide Y receptors: a promising target for cancer imaging and therapy. Regen Biomater (2015) 0.77
The atypical antipsychotics clozapine and olanzapine promote down-regulation and display functional selectivity at human 5-HT7 receptors. Br J Pharmacol (2015) 0.75
Tumor Targeting and Pharmacokinetics of a Near-Infrared Fluorescent-Labeled δ-Opioid Receptor Antagonist Agent, Dmt-Tic-Cy5. Mol Pharm (2016) 0.75
Caveolae and sorting in the trans-Golgi network of epithelial cells. EMBO J (1993) 4.09
Turning off the signal: desensitization of beta-adrenergic receptor function. FASEB J (1990) 4.05
XVI. International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors. Pharmacol Rev (1998) 2.58
Neuropeptide Y: emerging evidence for a functional role in seizure modulation. Trends Neurosci (1999) 2.08
Neuropeptide Y: stimulation of feeding and drinking by injection into the paraventricular nucleus. Life Sci (1984) 2.08
A receptor subtype involved in neuropeptide-Y-induced food intake. Nature (1996) 1.96
Signal transduction of a G protein-coupled receptor in caveolae: colocalization of endothelin and its receptor with caveolin. Proc Natl Acad Sci U S A (1994) 1.88
Regulatory mechanisms that modulate signalling by G-protein-coupled receptors. Biochem J (1997) 1.77
Neuropeptide Y distribution in human brain. Nature (1984) 1.66
Centrally administered neuropeptide Y (NPY) produces anxiolytic-like effects in animal anxiety models. Psychopharmacology (Berl) (1989) 1.55
Paradoxical trafficking and regulation of 5-HT(2A) receptors by agonists and antagonists. Brain Res Bull (2001) 1.53
Dual pathways of internalization of the cholecystokinin receptor. J Cell Biol (1995) 1.33
Neuropeptide Y and neuropeptide Y receptor subtypes in brain and peripheral tissues. Prog Neurobiol (1992) 1.33
Antagonist-stimulated internalization of the G protein-coupled cholecystokinin receptor. Mol Pharmacol (1997) 1.27
Transfer of M2 muscarinic acetylcholine receptors to clathrin-derived early endosomes following clathrin-independent endocytosis. J Biol Chem (2002) 1.19
Molecular cloning of a novel G protein-coupled receptor that may belong to the neuropeptide receptor family. FEBS Lett (1990) 1.17
Diverse functions of neuropeptide Y revealed using genetically modified animals. Neuropeptides (2002) 1.14
GR231118 (1229U91) and other analogues of the C-terminus of neuropeptide Y are potent neuropeptide Y Y1 receptor antagonists and neuropeptide Y Y4 receptor agonists. Eur J Pharmacol (1998) 1.08
BIBP 3226, the first selective neuropeptide Y1 receptor antagonist: a review of its pharmacological properties. Regul Pept (1996) 0.99
Monitoring of the internalization of neuropeptide Y on neuroblastoma cell line SK-N-MC. Eur J Biochem (2000) 0.99
Antagonist-induced intracellular sequestration of rabbit bradykinin B(2) receptor. Hypertension (2000) 0.99
Rapid internalization and recycling of the human neuropeptide Y Y(1) receptor. J Biol Chem (2001) 0.98
Characterization of neuropeptide Y binding sites in rat brain membrane preparations using [125I][Leu31,Pro34]peptide YY and [125I]peptide YY3-36 as selective Y1 and Y2 radioligands. J Pharmacol Exp Ther (1995) 0.97
Cloned neuropeptide Y (NPY) Y1 and pancreatic polypeptide Y4 receptors expressed in Chinese hamster ovary cells show considerable agonist-driven internalization, in contrast to the NPY Y2 receptor. Eur J Biochem (2001) 0.94
Molecular mechanisms of angiotensin II receptor internalization. J Am Soc Nephrol (1999) 0.91
[(125)I]-GR231118: a high affinity radioligand to investigate neuropeptide Y Y(1) and Y(4) receptors. Br J Pharmacol (2000) 0.91
Agonist and antagonist-dependent internalization of the human vasopressin V2 receptor. Exp Cell Res (1998) 0.91
Ligand-induced internalization of neurotensin in transfected COS-7 cells: differential intracellular trafficking of ligand and receptor. J Cell Sci (2000) 0.89
Differential internalization of somatostatin in COS-7 cells transfected with SST1 and SST2 receptor subtypes: a confocal microscopic study using novel fluorescent somatostatin derivatives. Endocrinology (1997) 0.89
Neuropeptide Y induced increase of cytosolic and nuclear Ca2+ in heart and vascular smooth muscle cells. Can J Physiol Pharmacol (2000) 0.87
Synthesis and characterization of a selective peptide antagonist of neuropeptide Y vascular postsynaptic receptors. Br J Pharmacol (1996) 0.87
Distribution of a novel hypothalamic neuropeptide Y receptor gene and it's absence in rat. Brain Res Mol Brain Res (1998) 0.87
Agonist internalization by cloned Y1 neuropeptide Y (NPY) receptor in Chinese hamster ovary cells shows strong preference for NPY, endosome-linked entry and fast receptor recycling. Regul Pept (2002) 0.83
Pharmacological evaluation of 1229U91, a novel high-affinity and selective neuropeptide Y-Y1 receptor antagonist. J Pharmacol Exp Ther (1995) 0.82
Internalization and trafficking of opioid receptor ligands in rat cortical neurons. Synapse (2002) 0.81
Expression of the neuropeptide Y Y1 receptor in human embryonic kidney 293 cells: ligand binding characteristics, in situ hybridization and receptor autoradiography. Brain Res Mol Brain Res (1995) 0.81
Sub-population of cultured hippocampal astrocytes expresses neuropeptide Y Y(1) receptors. Glia (2000) 0.81
Pharmacological characterization of (125)I-1229U91 binding to Y1 and Y4 neuropeptide Y/Peptide YY receptors. J Pharmacol Exp Ther (2000) 0.78
Bioassays for NPY receptors: old and new. Regul Pept (1998) 0.77
Role of NPY Y1 receptors in cardiovascular control in the conscious rabbit. J Cardiovasc Pharmacol (2000) 0.77
Neuropeptide Y and cerebral blood flow. Lancet (1985) 0.77
Pituitary adenylate cyclase-activating polypeptide and its receptors: 20 years after the discovery. Pharmacol Rev (2009) 3.22
Alzheimer's disease and the basal forebrain cholinergic system: relations to beta-amyloid peptides, cognition, and treatment strategies. Prog Neurobiol (2002) 2.03
The p38 subunit of the aminoacyl-tRNA synthetase complex is a Parkin substrate: linking protein biosynthesis and neurodegeneration. Hum Mol Genet (2003) 1.83
Psychosis pathways converge via D2high dopamine receptors. Synapse (2006) 1.78
Sex and gender reporting in health research: why Canada should be a leader. Can J Public Health (2012) 1.67
French multicentric survey of outcome of pregnancy in women with pregestational diabetes. Diabetes Care (2003) 1.46
Morphine and pain-related stimuli enhance cell surface availability of somatic delta-opioid receptors in rat dorsal root ganglia. J Neurosci (2006) 1.43
The neurocircuitry and receptor subtypes mediating anxiolytic-like effects of neuropeptide Y. Neurosci Biobehav Rev (2002) 1.41
Neuroprotective effects of resveratrol against beta-amyloid-induced neurotoxicity in rat hippocampal neurons: involvement of protein kinase C. Br J Pharmacol (2004) 1.35
Comparative signaling pathways of insulin-like growth factor-1 and brain-derived neurotrophic factor in hippocampal neurons and the role of the PI3 kinase pathway in cell survival. J Neurochem (2004) 1.33
Apoptosis-inducing factor: a matter of neuron life and death. Prog Neurobiol (2007) 1.31
Regulation of delta-opioid receptor trafficking via mu-opioid receptor stimulation: evidence from mu-opioid receptor knock-out mice. J Neurosci (2003) 1.26
The global alliance for chronic diseases. Science (2009) 1.23
A microdialysis profile of beta-endorphin and catecholamines in the rat nucleus accumbens following alcohol administration. Psychopharmacology (Berl) (2003) 1.23
Oxytocin-induced analgesia and scratching are mediated by the vasopressin-1A receptor in the mouse. J Neurosci (2010) 1.21
Neuroprotective effects of green and black teas and their catechin gallate esters against beta-amyloid-induced toxicity. Eur J Neurosci (2006) 1.20
FoxO-dependent and -independent mechanisms mediate SirT1 effects on IGFBP-1 gene expression. Biochem Biophys Res Commun (2005) 1.19
FKHRL1 and its homologs are new targets of nerve growth factor Trk receptor signaling. J Neurochem (2002) 1.18
Selective mediation of nerve injury-induced tactile hypersensitivity by neuropeptide Y. J Neurosci (2002) 1.18
Phylogenetic changes in the expression of delta opioid receptors in spinal cord and dorsal root ganglia. J Comp Neurol (2003) 1.15
The neurotrophic effects of PACAP in PC12 cells: control by multiple transduction pathways. J Neurochem (2006) 1.14
Cell-type specific activation of p38 and ERK mediates calcitonin gene-related peptide involvement in tolerance to morphine-induced analgesia. FASEB J (2009) 1.11
A microdialysis profile of Met-enkephalin release in the rat nucleus accumbens following alcohol administration. Alcohol Clin Exp Res (2005) 1.11
Interactions with PDZ domain proteins PIST/GOPC and PDZK1 regulate intracellular sorting of the somatostatin receptor subtype 5. J Biol Chem (2005) 1.11
Distribution of NTS3 receptor/sortilin mRNA and protein in the rat central nervous system. J Comp Neurol (2003) 1.10
Neuropeptide Y (NPY) Y2 receptors mediate behaviour in two animal models of anxiety: evidence from Y2 receptor knockout mice. Behav Brain Res (2003) 1.09
Molecular basis of programmed cell death involved in neurodegeneration. Trends Neurosci (2005) 1.09
Altered processing of the neurotensin/neuromedin N precursor in PC2 knock down mice: a biochemical and immunohistochemical study. J Neurochem (2002) 1.08
Neurotrophic effects of PACAP in the cerebellar cortex. Peptides (2007) 1.07
Successful cognitive aging in rats: a role for mGluR5 glutamate receptors, homer 1 proteins and downstream signaling pathways. PLoS One (2012) 1.07
Urotensin II, from fish to human. Ann N Y Acad Sci (2010) 1.04
A microdialysis profile of dynorphin A(1-8) release in the rat nucleus accumbens following alcohol administration. Alcohol Clin Exp Res (2006) 1.04
The neuropeptide Y (NPY) Y1 receptor subtype mediates NPY-induced antidepressant-like activity in the mouse forced swimming test. Neuropsychopharmacology (2002) 1.04
Dehydration-induced cross-regulation of apelin and vasopressin immunoreactivity levels in magnocellular hypothalamic neurons. Endocrinology (2004) 1.03
Inflammatory mediators modulating the transient receptor potential vanilloid 1 receptor: therapeutic targets to treat inflammatory and neuropathic pain. Expert Opin Ther Targets (2007) 1.03
A possible role of neuropeptide Y in depression and stress. Brain Res (2009) 1.02
Estrogen effects on object memory and cholinergic receptors in young and old female mice. Neurobiol Aging (2001) 1.02
Morphine-induced changes in delta opioid receptor trafficking are linked to somatosensory processing in the rat spinal cord. J Neurosci (2004) 1.02
Selenoprotein T is a PACAP-regulated gene involved in intracellular Ca2+ mobilization and neuroendocrine secretion. FASEB J (2008) 1.01
PACAP and NGF regulate common and distinct traits of the sympathoadrenal lineage: effects on electrical properties, gene markers and transcription factors in differentiating PC12 cells. Eur J Neurosci (2003) 1.01
Mu-opioid receptor knockout prevents changes in delta-opioid receptor trafficking induced by chronic inflammatory pain. Pain (2004) 1.01
Inhibitory effect of PACAP on caspase activity in neuronal apoptosis: a better understanding towards therapeutic applications in neurodegenerative diseases. J Mol Neurosci (2008) 1.01
Long-lasting rescue of age-associated deficits in cognition and the CNS cholinergic phenotype by a partial agonist peptidomimetic ligand of TrkA. J Neurosci (2004) 1.01
Pharmacological characterization of human NPFF(1) and NPFF(2) receptors expressed in CHO cells by using NPY Y(1) receptor antagonists. Eur J Pharmacol (2002) 0.99
Molecular and conformational determinants of pituitary adenylate cyclase-activating polypeptide (PACAP) for activation of the PAC1 receptor. J Med Chem (2009) 0.99
Insulin-like growth factor-1 (IGF-1) induces the activation/phosphorylation of Akt kinase and cAMP response element-binding protein (CREB) by activating different signaling pathways in PC12 cells. BMC Neurosci (2006) 0.99
Lipopolysaccharide induces calcitonin gene-related peptide in the RAW264.7 macrophage cell line. Immunology (2010) 0.99
Simvastatin improves cerebrovascular function and counters soluble amyloid-beta, inflammation and oxidative stress in aged APP mice. Neurobiol Dis (2009) 0.98
cDNA microarray and proteomic approaches in the study of brain diseases: focus on schizophrenia and Alzheimer's disease. Pharmacol Ther (2003) 0.97
Immunohistochemical distribution of NTS2 neurotensin receptors in the rat central nervous system. J Comp Neurol (2003) 0.97
Does COX2-dependent PGE2 play a role in neuropathic pain? Neurosci Lett (2008) 0.96
Protective effects of pituitary adenylate cyclase-activating polypeptide (PACAP) against apoptosis. Curr Pharm Des (2011) 0.96
Pituitary adenylate cyclase-activating polypeptide inhibits food intake in mice through activation of the hypothalamic melanocortin system. Neuropsychopharmacology (2008) 0.96
Pituitary adenylate cyclase-activating polypeptide protects rat cerebellar granule neurons against ethanol-induced apoptotic cell death. Proc Natl Acad Sci U S A (2002) 0.96
Nuclear/cytoplasmic shuttling of the transcription factor FoxO1 is regulated by neurotrophic factors. J Neurochem (2005) 0.96
Glutamate acting on N-methyl-D-aspartate receptors attenuates insulin-like growth factor-1 receptor tyrosine phosphorylation and its survival signaling properties in rat hippocampal neurons. J Biol Chem (2008) 0.95
Neuropeptide Y (NPY) and depression: from animal studies to the human condition. Life Sci (2002) 0.95
Characterization of neuropeptide Y, Y(2) receptor knockout mice in two animal models of learning and memory processing. J Mol Neurosci (2004) 0.95
α7 Nicotinic receptor activation reduces β-amyloid-induced apoptosis by inhibiting caspase-independent death through phosphatidylinositol 3-kinase signaling. J Neurochem (2011) 0.95
Transthyretin: a key gene involved in the maintenance of memory capacities during aging. Neurobiol Aging (2007) 0.94
Chromosome 13q13-q14 locus overlaps mood and psychotic disorders: the relevance for redefining phenotype. Eur J Hum Genet (2009) 0.93
Natural extracts as possible protective agents of brain aging. Neurobiol Aging (2002) 0.92
Morphological reorganization after repeated corticosterone administration in the hippocampus, nucleus accumbens and amygdala in the rat. J Chem Neuroanat (2009) 0.92
Protective action of resveratrol in human skin: possible involvement of specific receptor binding sites. PLoS One (2010) 0.92
Tyrosine-based rivastigmine-loaded organogels in the treatment of Alzheimer's disease. Biomaterials (2010) 0.92
Receptor trafficking via the perinuclear recycling compartment accompanied by cell division is necessary for permanent neurotensin cell sensitization and leads to chronic mitogen-activated protein kinase activation. J Biol Chem (2003) 0.92
Prolonged morphine treatment selectively increases membrane recruitment of delta-opioid receptors in mouse basal ganglia. J Mol Neurosci (2005) 0.92
Microarray and suppression subtractive hybridization analyses of gene expression in pheochromocytoma cells reveal pleiotropic effects of pituitary adenylate cyclase-activating polypeptide on cell proliferation, survival, and adhesion. Endocrinology (2003) 0.92
Alterations in hippocampal network oscillations and theta-gamma coupling arise before Aβ overproduction in a mouse model of Alzheimer's disease. Eur J Neurosci (2013) 0.91
Potent spinal analgesia elicited through stimulation of NTS2 neurotensin receptors. J Neurosci (2005) 0.91
Novel stable PACAP analogs with potent activity towards the PAC1 receptor. Peptides (2008) 0.91
Opposite regulation of the mitochondrial apoptotic pathway by C2-ceramide and PACAP through a MAP-kinase-dependent mechanism in cerebellar granule cells. J Neurochem (2004) 0.91
Internalization and trafficking of neurotensin via NTS3 receptors in HT29 cells. Int J Biochem Cell Biol (2004) 0.91
Pituitary adenylate cyclase-activating polypeptide prevents C2-ceramide-induced apoptosis of cerebellar granule cells. J Neurosci Res (2003) 0.90
Low-affinity neurotensin receptor (NTS2) signaling: internalization-dependent activation of extracellular signal-regulated kinases 1/2. Mol Pharmacol (2004) 0.90
Specific plasma membrane binding sites for polyphenols, including resveratrol, in the rat brain. J Pharmacol Exp Ther (2006) 0.90
PACAP and a novel stable analog protect rat brain from ischemia: Insight into the mechanisms of action. Peptides (2011) 0.89
Effect of Mas-related gene (Mrg) receptors on hyperalgesia in rats with CFA-induced inflammation via direct and indirect mechanisms. Br J Pharmacol (2013) 0.89
Chronically elevated endothelin levels reduce pulmonary vascular reactivity to nitric oxide. Am J Respir Crit Care Med (2004) 0.89
Insulin-like growth factor 1 prevents neuronal cell death induced by corticosterone through activation of the PI3k/Akt pathway. J Neurosci Res (2004) 0.89
Role of central calcitonin gene-related peptide (CGRP) in locomotor and anxiety- and depression-like behaviors in two mouse strains exhibiting a CGRP-dependent difference in thermal pain sensitivity. J Mol Neurosci (2009) 0.89
A large tandem duplication within the COL4A5 gene is responsible for the high prevalence of Alport syndrome in French Polynesia. Kidney Int (2004) 0.89
Modulation of NMDA receptors by intrathecal administration of the sensory neuron-specific receptor agonist BAM8-22. Neuropharmacology (2007) 0.88